NCT00002114View on ClinicalTrials.gov

A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 1994

Conditions
HIV Infections
Interventions
DRUG

Procysteine

Sponsors
All Listed Sponsors
lead

Free Radical Sciences

INDUSTRY

NCT00002114 - A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides | Biotech Hunter | Biotech Hunter